Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Solid Tumors

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: SCLC
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Colon Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

CX-839-014 "KEAPSAKE": A Phase 2, Randomized, Multicenter, Double-blind, Study of the Glutaminase Inhibitor Telaglenastat with Pembrolizumab and Chemotherapy versus Placebo with Pembrolizumab and Chemotherapy in First-line Metastatic KEAP1/NRF2-mutated Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

  • Details

ClinicalTrials.gov ID: NCT04265534
Diagnosis Type: NA
USOR Number: 19239

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma Who Are at High Risk of Recurrence after Curative Hepatic Resection or Ablation (CA209-9DX)

  • Details

ClinicalTrials.gov ID: NCT03383458
Diagnosis Type: NA
USOR Number: 19086

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Multicenter, Double-Blind, Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Sintilimab vs. Placebo, in Combination with Chemotherapy, for First-Line Treatment of Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma (ORIENT-15)CIBI308A301

  • Details

ClinicalTrials.gov ID: NCT03748134
Diagnosis Type: NA
USOR Number: 20171

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Edina

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

  • Details

ClinicalTrials.gov ID: NCT03646123
Diagnosis Type: Hodgkins
USOR Number: 18013

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Edina

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Minnesota Oncology - Edina

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PCR2002 Quest) (64091742PCR2002)

  • Details

ClinicalTrials.gov ID: NCT03431350
Diagnosis Type: NA
USOR Number: 19146

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN) (D9106C00001)

  • Details

ClinicalTrials.gov ID: NCT03800134
Diagnosis Type: NA
USOR Number: 19211

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer (NuTide:121)

  • Details

ClinicalTrials.gov ID: NCT04163900
Diagnosis Type: NA
USOR Number: 19120

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer (CA209-650)

  • Details

ClinicalTrials.gov ID: NCT02985957
Diagnosis Type: NA
USOR Number: 19135

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Pages